v3.26.1
Loss Per Ordinary Share - Schedule of Reconciliation of Basic and Diluted (Details) - USD ($)
6 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Numerator:    
Net (loss) income $ (209,004) $ 8,998
Less: net (loss) income attributable to non-controlling interest (101,269) 98,006
Net loss attributable to Jin Medical International Ltd. $ (107,735) $ (89,008)
Denominator:    
Weighted average shares outstanding - basic (in Shares) [1] 7,827,357 7,827,355
Weighted average shares outstanding - diluted (in Shares) [1] 7,827,357 7,827,355
Loss per ordinary share    
Basic (in Dollars per share) $ (0.01) $ (0.01)
Diluted (in Dollars per share) $ (0.01) $ (0.01)
[1] Retrospectively adjusted to reflect the 1-for-20 reverse share split effective on March 16, 2026.